GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 17
- 13F valueReported value at the end of Q2 2026
- $625.5K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GOVX, Q2 2026
No superinvestor reported holding GOVX at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by GeoVax Labs, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 20, 2025 (view filing) | Oct 17 | 3 days | Spencer John N JrDirector | PPurchase | +10.0K | $0.55 | +$5.50K | +87.7%21.4K after | |
| Aug 8, 2025 (view filing) | Aug 7 | 1 day | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +1.11K | $0.67 | +$741.69 | +46.4%3.49K after | |
| Apr 11, 2025 (view filing) | Apr 10 | 1 day | Spencer John N JrDirector | PPurchase | +10.0K | $0.98 | +$9.80K | +713.3%11.4K after | |
| Apr 10, 2025 (view filing) | Apr 10 | Same day | Sharkey John W.VP, Business Development | PPurchase | +6.00K | $0.99 | +$5.94K | +3,141.4%6.19K after | |
| Apr 1, 2025 (view filing) | Apr 1 | Same day | Dodd David APresident, CEO | PPurchase | +10.0K | $1.08 | +$10.8K | +37.5%36.7K after | |
| Mar 31, 2025 (view filing) | Mar 31 | Same day | Reynolds MarkCFO | PPurchase | +6.80K | $1.08 | +$7.34K | +94.3%14.0K after | |
| Aug 12, 2024 (view filing) | Aug 9 | 3 days | Dodd David APresident, CEO | PPurchase | +8.00K | $1.95 | +$15.6K | +42.9%26.7K after | |
| Feb 22, 2024 (view filing) | Feb 21-22 | 1 day | Dodd David APresident, CEO | PPurchase | +8.73K | $2.26 | +$19.8K | +87.9%18.7K after | 2 lots |
| Feb 7, 2024 (view filing) | Feb 7 | Same day | Reynolds MarkCFO | PPurchase | +2.00K | $2.77 | +$5.54K | +38.4%7.21K after | |
| Dec 26, 2023 (view filing)3:51 PM ET | Dec 22 | 4 days | McKee Kelly T. Jr.Chief Medical Officer | PPurchase | +6.94K | $0.36 | +$2.50K | +24.1%35.8K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in GeoVax Labs, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 315,275 | $400.4K | 0.00% | +315,275 | New |
| HRT Financial LP | 126,704 | $160.0K | 0.00% | +126,704 | New |
| Geode Capital Management, LLC | 21,112 | $26.8K | 0.00% | −14,964−41.5% | Reduced |
| Two Sigma Securities, LLC | 10,682 | $13.6K | 0.00% | +10,682 | New |
| Vanguard Fiduciary Trust Co | 5,068 | $6.44K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,502 | $4.45K | 0.00% | −25−0.7% | Reduced |
| Vanguard Capital Management LLC | 3,217 | $4.09K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2,588 | $3.29K | 0.00% | +2,204+574.0% | Added |
| Morgan Stanley | 2,003 | $2.54K | 0.00% | +1,997+33,283.3% | Added |
| Jones Financial Companies LLLP | 1,000 | $1.32K | 0.00% | +1,000 | New |